Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration

This study had two goals: 1) to evaluate the biological effect of the novel pentacyclic acridine 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) on human melanoma lines possessing long telomeres, and 2) to elucidate the relationship between G-quadruplex-based telomerase inhibitor-induced cellular effects and telomere length/dysfunction. The cellular pharmacological effects of RHPS4 have been evaluated by treating melanoma lines with increasing concentrations of RHPS4. A dose-dependent inhibition of cell proliferation was observed in all the lines during short-term treatment. Flow cytometric analysis demonstrated that RHPS4 induced a dose-dependent accumulation of cells in the S-G2/M phase of cell cycle. The RHPS4-induced cell cycle alteration was irreversible even at low doses, and the cells died from apoptosis. At high RHPS4 concentration, apoptosis was accompanied by the induction of a senescence phenotype: large cell size, vacuolated cytoplasm, and β-galactosidase activity. The short-term biological activity of RHPS4 was not caused by telomere shortening, but it was associated with telomere dysfunction, in terms of presence of telomeric fusions, polynucleated cells, and typical images of telophase bridge. In conclusion, our results demonstrate that the G-quadruplex ligand RHPS4 can function in a telomere length-independent manner through its ability to cause telomere-capping alteration.

[1]  J. Mergny,et al.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Raymond,et al.  Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.

[3]  O. Fedoroff,et al.  Induction of Duplex to G-quadruplex Transition in the c-myc Promoter Region by a Small Molecule* , 2001, The Journal of Biological Chemistry.

[4]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[5]  R. Wheelhouse,et al.  Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. , 2001, Journal of medicinal chemistry.

[6]  David M. Prescott,et al.  Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.

[7]  A. Schnapp,et al.  A highly selective telomerase inhibitor limiting human cancer cell proliferation , 2001, The EMBO journal.

[8]  S. Neidle,et al.  2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.

[9]  S. Neidle,et al.  Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.

[10]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[11]  S. Neidle,et al.  Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. , 1999, Anti-cancer drug design.

[12]  S. Neidle,et al.  Human telomerase inhibition by substituted acridine derivatives. , 1999, Bioorganic & medicinal chemistry letters.

[13]  G. Zupi,et al.  Inhibition of c-Myc Oncoprotein Limits the Growth of Human Melanoma Cells by Inducing Cellular Crisis* , 2003, Journal of Biological Chemistry.

[14]  T. Tsuruo,et al.  FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. , 1999, Cancer research.

[15]  G. Zupi,et al.  Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells. , 2003, Molecular pharmacology.

[16]  D. Corey,et al.  Inhibition of human telomerase activity by peptide nucleic acids , 1996, Nature Biotechnology.

[17]  Bas van Steensel,et al.  TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.

[18]  D. Corey,et al.  Inhibition of human telomerase by 2'-O-methyl-RNA. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Neidle,et al.  A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.

[20]  E. Raymond,et al.  Preclinical and clinical strategies for development of telomerase and telomere inhibitors. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[22]  Charles A Laughton,et al.  Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. , 2002, Journal of medicinal chemistry.

[23]  W. Hahn,et al.  Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.

[24]  Y. Kondo,et al.  2-5A antisense telomerase RNA therapy for intracranial malignant gliomas. , 2000, Cancer research.

[25]  E. Blackburn,et al.  Telomere states and cell fates , 2000, Nature.

[26]  K. Shin‐ya,et al.  Resistance to the Short Term Antiproliferative Activity of the G-quadruplex Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration* , 2003, Journal of Biological Chemistry.

[27]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[28]  C. Leonetti,et al.  Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones , 2002, Oncogene.

[29]  S. Neidle,et al.  1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.

[30]  M. Entman,et al.  Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Mizoguchi,et al.  Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. , 2002, Cancer letters.

[32]  O. Fedoroff,et al.  NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.

[33]  M. Searle,et al.  Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. , 2003, Journal of Molecular Biology.

[34]  E. Blackburn,et al.  A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Broccoli,et al.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. , 1999, Science.

[36]  L. Hurley,et al.  The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. , 2003, Cancer research.

[37]  M. Stevens,et al.  Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.